Literature DB >> 12539263

Polar mutations in membrane proteins as a biophysical basis for disease.

Anthony W Partridge1, Alex G Therien, Charles M Deber.   

Abstract

Transmembrane (TM) alpha-helices are surrounded by the hydrocarbon chains of the lipid bilayer. The low dielectric constant of this environment makes it extremely unfavorable for a residue with a polar side chain to exist in a non-H-bonded state. Therefore, in combination with a wild-type polar residue partner, a polar TM mutant could generate, in some cases, a non-native H-bond that could impair native protein structure/function-and possibly lead to a disease state. We have examined protein mutation databases and have found many examples of TM-based apolar to polar mutations that are, in fact, a cause of human disease. Here we review the various molecular defects that such mutations can produce, including impeding protein dynamics by side-chain-side-chain interhelical H-bond cross-links; alteration of helical packing through steric hindrance; and disruption of a protein active site. We further note that the reverse case--membrane-embedded polar to apolar mutations--can similarly cause human disease, implying that native interhelical H-bonds can also play pivotal roles in stabilizing native TM domains. As a specific example, we show that the Gly to Arg mutation occurs statistically more frequently in TM domains as compared to its occurrence in soluble domains, suggesting that TM-based G-to-R mutations have a high "phenotypic propensity" for disease. A more complete understanding of how mutations involving polar residues in TM domains of proteins translate into compromised function may aid in the development of novel therapeutics. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12539263     DOI: 10.1002/bip.10313

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  16 in total

Review 1.  Membrane protein folding: how important are hydrogen bonds?

Authors:  James U Bowie
Journal:  Curr Opin Struct Biol       Date:  2010-11-12       Impact factor: 6.809

2.  Noncovalent keystone interactions controlling biomembrane structure.

Authors:  Roger G Hanshaw; Robert V Stahelin; Bradley D Smith
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease.

Authors:  Masayoshi Sakakura; Arina Hadziselimovic; Zhen Wang; Kevin L Schey; Charles R Sanders
Journal:  Structure       Date:  2011-08-10       Impact factor: 5.006

4.  Structural organization of FtsB, a transmembrane protein of the bacterial divisome.

Authors:  Loren M LaPointe; Keenan C Taylor; Sabareesh Subramaniam; Ambalika Khadria; Ivan Rayment; Alessandro Senes
Journal:  Biochemistry       Date:  2013-04-04       Impact factor: 3.162

5.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

6.  Polar residues and their positional context dictate the transmembrane domain interactions of influenza A neuraminidases.

Authors:  Johan Nordholm; Diogo V da Silva; Justina Damjanovic; Dan Dou; Robert Daniels
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

7.  Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins.

Authors:  Nathan Hyunjoong Joh; Andrew Min; Salem Faham; Julian P Whitelegge; Duan Yang; Virgil L Woods; James U Bowie
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

8.  Conserved polar residues stabilize transmembrane domains and promote oligomerization in human nucleoside triphosphate diphosphohydrolase 3.

Authors:  Keith J Gaddie; Terence L Kirley
Journal:  Biochemistry       Date:  2009-10-13       Impact factor: 3.162

9.  Phenotype-optimized sequence ensembles substantially improve prediction of disease-causing mutation in cystic fibrosis.

Authors:  David L Masica; Patrick R Sosnay; Garry R Cutting; Rachel Karchin
Journal:  Hum Mutat       Date:  2012-05-22       Impact factor: 4.878

10.  Alteration of CFTR transmembrane span integration by disease-causing mutations.

Authors:  Anna E Patrick; Andrey L Karamyshev; Linda Millen; Philip J Thomas
Journal:  Mol Biol Cell       Date:  2011-10-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.